Barbara Harlin Bispham serves as Executive at CRESCENT BIOPHARMA, INC., where they oversee executive responsibilities. Since joining the company, Barbara Harlin Bispham has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Dec 15, 2025 involved receiving (via award) 12,422 shares valued at $0.
Barbara Harlin Bispham currently holds 12,422 shares of CRESCENT BIOPHARMA, INC. (CBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Barbara Harlin Bispham has been a net neutral trader of CBIO stock. They have purchased $0 and sold $0 worth of shares.
Barbara Harlin Bispham's most recent insider trade was on Dec 15, 2025, when they sold 12,422 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |